Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linking composition and function: a two-year metatranscriptomic study of microbial adaptation in an industrial wastewater treatment plant.

FEMS microbiology ecology·2026
Same author

Horse Olfactory Exploration of Various Plants with Regard to Smell and Taste Familiarity.

Animals : an open access journal from MDPI·2026
Same author

Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach.

Nutrients·2026
Same author

The interplay of sleep characteristics with health factors and gut microbiome.

Nature communications·2026
Same author

Preliminary Biometric Study on Symmetry of Hoof Solear Aspect in Forelimbs in Four Horse Breeds.

Animals : an open access journal from MDPI·2025
Same author

<i>Lactobacillus iners</i> dominates the vaginal microbiota of healthy Italian women of reproductive age.

mSystems·2025

Related Experiment Video

Updated: Jun 21, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.8K

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing.

Ineke L Tan1,2, Rutger Modderman1, Anna Stachurska1

  • 1Department of Genetics, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.

Brain Communications
|July 9, 2024
PubMed
Summary

Researchers identified new protein and microRNA biomarkers in serum to differentiate multiple sclerosis subtypes. A peak in granzyme B and immune-related microRNAs signals conversion from relapsing-remitting to secondary progressive multiple sclerosis.

Keywords:
biomarkerdisease stagemicroRNA sequencingmultiple sclerosisproteomics

More Related Videos

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

4.5K
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.4K

Related Experiment Videos

Last Updated: Jun 21, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.8K
Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

4.5K
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.4K

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system demyelinating disease.
  • Current diagnostic and prognostic tools for MS subtypes are limited.
  • Need for circulating biomarkers to guide treatment decisions in MS.

Purpose of the Study:

  • To identify novel protein and microRNA biomarkers in cerebrospinal fluid and serum for multiple sclerosis (MS).
  • To differentiate between MS subtypes, specifically relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS).
  • To investigate biomarkers associated with the conversion from RRMS to SPMS.

Main Methods:

  • Targeted proteomics (92 proteins) and microRNA sequencing on serum and cerebrospinal fluid samples.
  • Analysis of a cross-sectional case-control cohort (Cohort I) and a prospective MS cohort (Cohort II).
  • Meta-analysis combining data from both cohorts to identify differentially expressed markers.

Main Results:

  • 13 proteins differed between MS and controls in cerebrospinal fluid; no microRNAs.
  • Serum analysis revealed 10 proteins and 16 microRNAs differentiating RRMS from SPMS.
  • Longitudinal analysis showed a peak in granzyme B proteins and enrichment of immune cell-related microRNAs during RRMS to SPMS conversion.

Conclusions:

  • Serum proteins and microRNAs show potential as biomarkers for distinguishing MS subtypes.
  • Conversion to SPMS is associated with increased granzyme B and specific immune microRNAs.
  • Immune cell-driven processes may play a role in MS progression.